Indication
Infertility associated with anovulation
Infertility associated with anovulation is a reproductive disorder in females of childbearing age characterized by the inability to conceive due to the complete absence of mature oocyte release from the ovaries. Read more about Infertility associated with anovulation
25 drugs 17 manufacturers
Drugs that treat it
Common Infertility associated with anovulation therapies.
CLOMIPHENE CITRATE
MILOPHENE (clomiphene citrate)
CLOMIPHENE CITRATE
CLOMIPHENE CITRATE
CLOMIPHENE CITRATE
CLOMIPHENE CITRATE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonInfertility associated with anovulation is a reproductive disorder in females of childbearing age characterized by the inability to conceive due to the complete absence of mature oocyte release from the ovaries.
This condition stems from disruptions along the hypothalamic-pituitary-ovarian axis, which impairs the regular cyclical surges of gonadotropins—luteinizing hormone and follicle-stimulating hormone—necessary to trigger follicular maturation and ovulation.
Clinically, affected individuals typically present with irregular menstrual patterns, such as oligomenorrhea, secondary amenorrhea, or unpredictable abnormal uterine bleeding, frequently secondary to underlying endocrine conditions like polycystic ovary syndrome, hyperprolactinemia, or functional hypothalamic amenorrhea.
- nih.gov
Infertility associated with anovulation is a reproductive disorder in females of childbearing age characterized by the inability to conceive due to the complete absence of mature oocyte release from the ovaries
- womenandinfants.org
Infertility associated with anovulation is a reproductive disorder in females of childbearing age characterized by the inability to conceive due to the complete absence of mature oocyte release from the ovaries This condition stems from disruptions along the hypothalamic-pituitary-ovarian axis, which impairs the regular cyclical surges of gonadotropins—luteinizing hormone and follicle-stimulating hormone—necessary to trigger follicular maturation and ovulation
- nih.gov
This condition stems from disruptions along the hypothalamic-pituitary-ovarian axis, which impairs the regular cyclical surges of gonadotropins—luteinizing hormone and follicle-stimulating hormone—necessary to trigger follicular maturation and ovulation
- nih.gov
Clinically, affected individuals typically present with irregular menstrual patterns, such as oligomenorrhea, secondary amenorrhea, or unpredictable abnormal uterine bleeding, frequently secondary to underlying endocrine conditions like polycystic ovary syndrome, hyperprolactinemia, or functional hypothalamic amenorrhea
- nih.gov
Clinically, affected individuals typically present with irregular menstrual patterns, such as oligomenorrhea, secondary amenorrhea, or unpredictable abnormal uterine bleeding, frequently secondary to underlying endocrine conditions like polycystic ovary syndrome, hyperprolactinemia, or functional hypothalamic amenorrhea
- merckmanuals.com
Clinically, affected individuals typically present with irregular menstrual patterns, such as oligomenorrhea, secondary amenorrhea, or unpredictable abnormal uterine bleeding, frequently secondary to underlying endocrine conditions like polycystic ovary syndrome, hyperprolactinemia, or functional hypothalamic amenorrhea
Personalize your experience
Follow Infertility associated with anovulation and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.